PT421 – Dr. Roberta Murphy – The Impact of the Therapeutic Alliance on the Psychedelic Experience

In this episode, David interviews Dr. Roberta Murphy: member of the Imperial Centre for Psychedelic Research and training medical psychotherapist. This is a rare impromptu podcast, recorded about a half hour after David heard Murphy speaking on a panel at UK's Breaking Convention conference. He asked her if she wanted to be on the podcast sometime, and before they knew it, they were recording. Fastest turnaround ever? She discusses her past research and what she's doing at Imperial College; her work on a psilocybin for depression trial; a psilocybin versus Escitalopram trial; her hopes for psychedelics treating people with Parkinson's; and her recent co-written paper on the ARC Framework (Access, Reciprocity and Conduct), where she will be focusing strongly on the Conduct aspect through her work at Imperial.  She mostly talks about her other recent paper exploring the impact of one of the more important aspects of therapy: the therapeutic alliance on the psychedelic experience. How does the treatment dynamic between the therapist and the client impact the outcome (and course) of the therapy, and what determines whether it's neutral, negative, positive, or very positive? Click here to head to the show notes page.